# Bivalent Norovirus Vaccine Study

> **NCT01168401** · PHASE1 · COMPLETED · sponsor: **Takeda** · enrollment: 102 (actual)

## Conditions studied

- Gastroenteritis

## Interventions

- **BIOLOGICAL:** NoV GI.1/GII.4 Bivalent VLP Vaccine
- **BIOLOGICAL:** Saline

## Key facts

- **NCT ID:** NCT01168401
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09-03
- **Primary completion:** 2013-01-01
- **Final completion:** 2013-01-09
- **Target enrollment:** 102 (ACTUAL)
- **Last updated:** 2018-11-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01168401

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01168401, "Bivalent Norovirus Vaccine Study". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01168401. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*